[New aspects of treatment of hemodynamic complications in acute myocardial infarction (author's transl)].
Following a description of hemodynamic and metabolic effects of an acute myocardial infarction, indications for a therapy with furosemide, isosorbiddinitrate, digitalis, canrenoate-potassium, and dopamine and the results thereof are discussed. Special consideration is given to the question of vasodilatory treatment with nitroprusside, phentolamine, and nitroglycerin infusion.
D000818:Animals; D002191:Canrenoic Acid / Q000494:pharmacology / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000494:pharmacology / Q000627:therapeutic use; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology / Q000627:therapeutic use; D005665:Furosemide / Q000494:pharmacology / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D005996:Nitroglycerin / Q000494:pharmacology / Q000627:therapeutic use; D010646:Phentolamine / Q000494:pharmacology / Q000627:therapeutic use; D012770:Shock, Cardiogenic / Q000188:drug therapy; D013148:Spironolactone / Q000494:pharmacology / Q000627:therapeutic use
D004071:Digitalis Glycosides; D013148:Spironolactone; D005665:Furosemide; D002191:Canrenoic Acid; D005996:Nitroglycerin; D004298:Dopamine; D010646:Phentolamine
Neuere Aspekte in der Behandlung hämodynamischer Komplikationen bei akutem Myokardinfarkt